$CMCT
Creative Media & Community Trust Corp Stock $cmct

$cmct Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000090831123000036 Filed on May 05, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$32.76M	$28.91M
YoY Change	24.08%	16.67%
Cost Of Revenue	$19.19M	$17.08M
YoY Change	29.85%	28.39%
Gross Profit	$13.57M	$11.83M
YoY Change	16.74%	3.08%
Gross Profit Margin	41.41%	40.92%
Selling, General & Admin	$1.684M	$5.285M
YoY Change	34.4%	191.18%
% of Gross Profit	12.41%	44.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.45M	$9.604M
YoY Change	307.65%	90.67%
% of Gross Profit	150.75%	81.18%
Operating Expenses	$22.16M	$14.79M
YoY Change	255.81%	116.85%
Operating Profit	-$8.589M	-$2.956M
YoY Change	-259.2%	-163.45%
Interest Expense	$8.709M	$6.236M
YoY Change	-506.39%	187.37%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$18.20M	-$7.320M
YoY Change	-659.72%	-380.57%
Income Tax	$159.0K	$256.0K
% Of Pretax Income
Net Earnings	-$17.36M	-$6.951M
YoY Change	-694.08%	-402.61%
Net Earnings / Revenue	-52.99%	-24.04%
Basic Earnings Per Share	-$1.05	-$0.56
Diluted Earnings Per Share	-$1.05	-$0.56
COMMON SHARES
Basic Shares Outstanding	22.74M shares	22.74M shares
Diluted Shares Outstanding	22.71M shares	22.71M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.56M	$22.49M
YoY Change	49.04%	31.87%
Cash & Equivalents	$24.56M	$22.49M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$4.673M	$7.982M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$29.23M	$30.47M
YoY Change	47.4%	52.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$711.8M	$715.9M
YoY Change	41.63%	43.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$27.53M	$28.38M
YoY Change	20.79%	25.95%
Other Assets	$56.56M	$58.24M
YoY Change	18.61%	18.06%
Total Long-Term Assets	$890.5M	$927.1M
YoY Change	35.35%	38.73%
TOTAL ASSETS
Total Short-Term Assets	$29.23M	$30.47M
Total Long-Term Assets	$890.5M	$927.1M
Total Assets	$919.7M	$957.6M
YoY Change	35.7%	39.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$31.48M	$31.45M
YoY Change	64.01%	96.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$36.21M	$35.32M
YoY Change	38.15%	61.72%
LONG-TERM LIABILITIES
Long-Term Debt	$487.8M	$520.7M
YoY Change	134.73%	128.2%
Other Long-Term Liabilities	$14.36M	$15.97M
YoY Change	-30.2%	-26.68%
Total Long-Term Liabilities	$502.2M	$536.7M
YoY Change	119.87%	114.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$36.21M	$35.32M
Total Long-Term Liabilities	$502.2M	$536.7M
Total Liabilities	$538.4M	$572.0M
YoY Change	111.16%	110.45%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$23.00K	$23.00K
YoY Change		-4.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$377.6M	$373.9M
YoY Change
Total Liabilities & Shareholders Equity	$919.7M	$957.6M
YoY Change	35.7%	39.13%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$17.36M	-$6.951M
YoY Change	-694.08%	-402.61%
Depreciation, Depletion And Amortization	$20.45M	$9.604M
YoY Change	307.65%	90.67%
Cash From Operating Activities	$6.654M	$2.766M
YoY Change	-60.03%	-67.98%
INVESTING ACTIVITIES
Capital Expenditures	$1.639M	$101.5M
YoY Change	-120.34%	-2280.52%
Acquisitions
YoY Change
Other Investing Activities	$15.02M	$10.48M
YoY Change	178.52%	-136.87%
Cash From Investing Activities	$13.38M	-$91.07M
YoY Change	-601.65%	175.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.52M	$77.66M
YoY Change	9.49%	262.67%
NET CHANGE
Cash From Operating Activities	6.654M	$2.766M
Cash From Investing Activities	13.38M	-$91.07M
Cash From Financing Activities	-18.52M	$77.66M
Net Change In Cash	1.511M	-$10.65M
YoY Change	-151.48%	251.62%
FREE CASH FLOW
Cash From Operating Activities	$6.654M	$2.766M
Capital Expenditures	$1.639M	$101.5M
Free Cash Flow	$5.015M	-$98.78M
YoY Change	-79.7%	-842.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000908311
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/srt/2022#HotelMember
CY2023Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/srt/2022#HotelMember
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-13610
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CREATIVE MEDIA & COMMUNITY TRUST CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-6446078
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	17950 Preston Road,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600,
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75252
CY2023Q1	dei	City Area Code CityAreaCode	(972)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	349-3200
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22737853	shares
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	715850000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	502006000	usd
CY2023Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	28375000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	12381000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22491000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46190000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	24342000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11290000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	62442000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	62547000	usd
CY2023Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	7982000	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	3780000	usd
CY2023Q1	cmct	Deferred Rent Receivable And Charges Net DeferredRentReceivableAndChargesNet	33894000	usd
CY2022Q4	cmct	Deferred Rent Receivable And Charges Net DeferredRentReceivableAndChargesNet	37543000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	572041000	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	27591000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	4461000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	34589000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	10050000	usd
CY2023Q1	us-gaap	Assets Assets	957556000	usd
CY2022Q4	us-gaap	Assets Assets	690248000	usd
CY2023Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	520748000	usd
CY2022Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	184267000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	31445000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	107220000	usd
CY2023Q1	us-gaap	Below Market Lease Net BelowMarketLeaseNet	234000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	20000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3877000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3155000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	15737000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	17856000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Liabilities Liabilities	312518000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	35246719	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	35246719	shares
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	302136	shares
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	302136	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	693741	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	693741	shares
CY2022Q4	us-gaap	Temporary Equity Liquidation Preference Per Share TemporaryEquityLiquidationPreferencePerShare	25.00
CY2023Q1	us-gaap	Temporary Equity Liquidation Preference Per Share TemporaryEquityLiquidationPreferencePerShare	25.00
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	6833000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	15697000	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22737853	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22737853	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22737853	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22737853	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	859029000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	861721000	usd
CY2023Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	853108000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	837846000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	373932000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	361660000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	4750000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	373000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	378682000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	362033000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	957556000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	690248000	usd
CY2023Q1	cmct	Operating Lease And Other Property Revenue OperatingLeaseAndOtherPropertyRevenue	14886000	usd
CY2022Q1	cmct	Operating Lease And Other Property Revenue OperatingLeaseAndOtherPropertyRevenue	14096000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10923000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7404000	usd
CY2023Q1	cmct	Interest And Other Operating Income InterestAndOtherOperatingIncome	3103000	usd
CY2022Q1	cmct	Interest And Other Operating Income InterestAndOtherOperatingIncome	3282000	usd
CY2023Q1	us-gaap	Revenues Revenues	28912000	usd
CY2022Q1	us-gaap	Revenues Revenues	24782000	usd
CY2023Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	15225000	usd
CY2022Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	11492000	usd
CY2023Q1	cmct	Related Party Asset Management Fees And Other Fees RelatedPartyAssetManagementFeesAndOtherFees	720000	usd
CY2022Q1	cmct	Related Party Asset Management Fees And Other Fees RelatedPartyAssetManagementFeesAndOtherFees	921000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	6236000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	2170000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1925000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1815000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3360000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9502000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5004000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	38104000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	22293000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	768000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	120000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1104000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7320000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2609000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	256000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	307000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7576000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2302000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-625000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6951000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2297000	usd
CY2023Q1	cmct	Redeemable Preferred Stock Dividends Declared And Accumulated RedeemablePreferredStockDividendsDeclaredAndAccumulated	5391000	usd
CY2022Q1	cmct	Redeemable Preferred Stock Dividends Declared And Accumulated RedeemablePreferredStockDividendsDeclaredAndAccumulated	5018000	usd
CY2023Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	0	usd
CY2022Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	15000	usd
CY2023Q1	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	373000	usd
CY2022Q1	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	75000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12715000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2811000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22707000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23349000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22707000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23351000	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	362033000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	5002000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	55000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.085
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1933000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7576000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	378682000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	373549000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	55000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.085
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1986000	usd
CY2022Q1	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	15000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2302000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	377460000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7576000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2302000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9604000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5037000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1104000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	395000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	297000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-3000	usd
CY2023Q1	cmct	Unrealized Premium Adjustment UnrealizedPremiumAdjustment	265000	usd
CY2022Q1	cmct	Unrealized Premium Adjustment UnrealizedPremiumAdjustment	573000	usd
CY2023Q1	cmct	Amortization And Accretion On Loans Receivable Net AmortizationAndAccretionOnLoansReceivableNet	99000	usd
CY2022Q1	cmct	Amortization And Accretion On Loans Receivable Net AmortizationAndAccretionOnLoansReceivableNet	150000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	109000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-339000	usd
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	56000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	55000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	55000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	768000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	120000	usd
CY2023Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	7849000	usd
CY2022Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	12369000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	6271000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	12211000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Loans Held For Sale ProceedsFromCollectionOfLoansHeldForSale	605000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Held For Sale ProceedsFromCollectionOfLoansHeldForSale	374000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-150000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-600000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4163000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-372000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5424000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3510000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14007000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1717000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	246000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	304000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2119000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4755000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	722000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1271000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2766000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8639000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	4816000	usd
CY2022Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	2383000	usd
CY2023Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	96731000	usd
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	2274000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	16714000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6626000	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	22408000	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	2932000	usd
CY2022Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	10407000	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	3323000	usd
CY2022Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	4393000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-91068000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33079000	usd
CY2023Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	108203000	usd
CY2022Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	12867000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	212000000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	40000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	54141000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	607000	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	374000	usd
CY2023Q1	cmct	Payments Of Deferred Stock Issuance Costs PaymentsOfDeferredStockIssuanceCosts	283000	usd
CY2022Q1	cmct	Payments Of Deferred Stock Issuance Costs PaymentsOfDeferredStockIssuanceCosts	223000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2400000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1933000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1753000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	23644000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	8942000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	9820000	usd
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11166000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	88884000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	1147000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	77655000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21412000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10647000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3028000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57480000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33651000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46833000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30623000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22491000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17055000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	24342000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	13568000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46833000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30623000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	4093000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1865000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3494000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1144000	usd
CY2023Q1	cmct	Proceeds From The Sale Of Real Estate Committed But Not Yet Paid ProceedsFromTheSaleOfRealEstateCommittedButNotYetPaid	17657000	usd
CY2022Q1	cmct	Proceeds From The Sale Of Real Estate Committed But Not Yet Paid ProceedsFromTheSaleOfRealEstateCommittedButNotYetPaid	0	usd
CY2023Q1	cmct	Other Amounts Due From Unconsolidated Joint Venture Partners Included In Other Assets OtherAmountsDueFromUnconsolidatedJointVenturePartnersIncludedInOtherAssets	1445000	usd
CY2022Q1	cmct	Other Amounts Due From Unconsolidated Joint Venture Partners Included In Other Assets OtherAmountsDueFromUnconsolidatedJointVenturePartnersIncludedInOtherAssets	0	usd
CY2023Q1	cmct	Non Cash Contributions To Unconsolidated Joint Venture NonCashContributionsToUnconsolidatedJointVenture	8600000	usd
CY2022Q1	cmct	Non Cash Contributions To Unconsolidated Joint Venture NonCashContributionsToUnconsolidatedJointVenture	0	usd
CY2023Q1	cmct	Stock Offering Costs Not Yet Paid StockOfferingCostsNotYetPaid	101000	usd
CY2022Q1	cmct	Stock Offering Costs Not Yet Paid StockOfferingCostsNotYetPaid	151000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1933000	usd
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1986000	usd
CY2023Q1	cmct	Accrual Of Dividends Payable To Preferred Stockholders AccrualOfDividendsPayableToPreferredStockholders	1832000	usd
CY2022Q1	cmct	Accrual Of Dividends Payable To Preferred Stockholders AccrualOfDividendsPayableToPreferredStockholders	3802000	usd
CY2023Q1	cmct	Offering Costs Offset Against Redeemable Preferred Stock Temporary Equity OfferingCostsOffsetAgainstRedeemablePreferredStockTemporaryEquity	403000	usd
CY2022Q1	cmct	Offering Costs Offset Against Redeemable Preferred Stock Temporary Equity OfferingCostsOffsetAgainstRedeemablePreferredStockTemporaryEquity	134000	usd
CY2023Q1	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	8812000	usd
CY2022Q1	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	7667000	usd
CY2023Q1	us-gaap	Notes Assumed1 NotesAssumed1	181318000	usd
CY2022Q1	us-gaap	Notes Assumed1 NotesAssumed1	0	usd
CY2023Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	0	usd
CY2022Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	15000	usd
CY2023Q1	cmct	Redeemable Preferred Stock Fees Incurred But Not Yet Paid RedeemablePreferredStockFeesIncurredButNotYetPaid	413000	usd
CY2022Q1	cmct	Redeemable Preferred Stock Fees Incurred But Not Yet Paid RedeemablePreferredStockFeesIncurredButNotYetPaid	596000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	5002000	usd
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-bottom:8pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. ORGANIZATION AND OPERATIONS</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Creative Media & Community Trust Corporation (formerly known as CIM Commercial Trust Corporation) (the “Company”), is a Maryland corporation and real estate investment trust (“REIT”). The Company primarily acquires, develops, owns and operates both premier multifamily properties situated in vibrant communities throughout the United States and Class A and creative office real assets in markets with similar business and employment characteristics to its multifamily investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also owns one hotel in northern California and a lending platform that originates loans under the Small Business Administration (“SBA”) 7(a) loan program. The Company seeks to apply the expertise of CIM Group, L.P. (“CIM Group”) to the acquisition, development and operation of premier multifamily properties and creative office assets that cater to rapidly growing industries such as technology, media and entertainment in vibrant and emerging communities throughout the United States.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s common stock, $0.001 par value per share (“Common Stock”), is currently traded on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CMCT”, and on the Tel Aviv Stock Exchange (the “TASE”) under the ticker symbol “CMCT.” The Company has authorized for issuance 900,000,000 shares of common stock and 100,000,000 shares of preferred stock (“Preferred Stock”). </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 2022, the Company has</span> been conducting a continuous public offering with respect to shares of its Series A1 Preferred Stock, par value $0.001 per share with an initial stated value of $25.00 per share, subject to adjustment (Note 11).
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q1	cmct	Preferred Stock Including Temporary Equity Shares Authorized PreferredStockIncludingTemporaryEquitySharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Fiscal Period FiscalPeriod	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interim Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The accompanying interim consolidated financial statements of the Company have been prepared by the Company’s management in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Certain information and note disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, the interim consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The accompanying financial information reflects all adjustments which are, in the opinion of the Company’s management, of a normal recurring nature and necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. The accompanying interim consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto, included in the 2022 Form 10-K.</span>
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	14886000	usd
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	14096000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	673000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	387000	usd
CY2023Q1	us-gaap	Incentive To Lessee IncentiveToLessee	3900000	usd
CY2022Q4	us-gaap	Incentive To Lessee IncentiveToLessee	3900000	usd
CY2023Q1	cmct	Incentive To Lessee Accumulated Amortization IncentiveToLesseeAccumulatedAmortization	3000000	usd
CY2022Q4	cmct	Incentive To Lessee Accumulated Amortization IncentiveToLesseeAccumulatedAmortization	3000000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	12474000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	11623000	usd
CY2023Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	2412000	usd
CY2022Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	2473000	usd
CY2023Q1	cmct	Tenant Reimbursements Excluding Lease Agreements TenantReimbursementsExcludingLeaseAgreements	0	usd
CY2022Q1	cmct	Tenant Reimbursements Excluding Lease Agreements TenantReimbursementsExcludingLeaseAgreements	0	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2023Q1	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	-8800000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	-9000000	usd
CY2023Q1	cmct	Loan And Leases Receivable Nonaccrual Loan And Lease Status Past Due Period LoanAndLeasesReceivableNonaccrualLoanAndLeaseStatusPastDuePeriod	P60D
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1100000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1900000	usd
CY2022Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	30000	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	18210000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	20949000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	9728000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	9637000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	7641000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	8319000	usd
CY2023Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	5577000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	5664000	usd
CY2023Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	213000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1975000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2120000	usd
CY2023Q1	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	491000	usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	491000	usd
CY2023Q1	cmct	Deferred Rent Receivable And Charges Net DeferredRentReceivableAndChargesNet	33894000	usd
CY2022Q4	cmct	Deferred Rent Receivable And Charges Net DeferredRentReceivableAndChargesNet	37543000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of consolidated financial statements in conformity with GAAP requires</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses during the reporting period. The Company bases such estimates on historical experience, information available at the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time, and assumptions the Company believes to be reasonable under the circumstances at such time. Actual results could</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">differ from those estimates.</span></div>
CY2023Q1	us-gaap	Land Land	175709000	usd
CY2022Q4	us-gaap	Land Land	151727000	usd
CY2023Q1	us-gaap	Land Improvements LandImprovements	6012000	usd
CY2022Q4	us-gaap	Land Improvements LandImprovements	1837000	usd
CY2023Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	632536000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	455275000	usd
CY2023Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	12468000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	4339000	usd
CY2023Q1	us-gaap	Tenant Improvements TenantImprovements	31066000	usd
CY2022Q4	us-gaap	Tenant Improvements TenantImprovements	34372000	usd
CY2023Q1	us-gaap	Development In Process DevelopmentInProcess	13490000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	12863000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	871281000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	660413000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	155431000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	158407000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	715850000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	502006000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	4800000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	4200000	usd
CY2023Q1	cmct	Percentage Of Ownership Acquired PercentageOfOwnershipAcquired	1
CY2022Q1	cmct	Number Of Properties Sold NumberOfPropertiesSold	0	property
CY2023Q1	cmct	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeases	223000	usd
CY2022Q1	cmct	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeases	0	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	283051000	usd
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	2274000	usd
CY2023Q1	cmct	Acquired Finite Lived Intangible Liabilities Useful Life AcquiredFiniteLivedIntangibleLiabilitiesUsefulLife	P5M
CY2023Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	28375000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	12381000	usd
CY2023Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	63106000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	62360000	usd
CY2023Q1	cmct	Financing Receivables Deferred Capitalized Costs Net FinancingReceivablesDeferredCapitalizedCostsNet	1276000	usd
CY2022Q4	cmct	Financing Receivables Deferred Capitalized Costs Net FinancingReceivablesDeferredCapitalizedCostsNet	1293000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1940000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1106000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	62442000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	62547000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1106000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	51000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1940000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	51000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27591000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4461000	usd
CY2023Q1	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	32000	usd
CY2022Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	22000	usd
CY2022	cmct	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P1Y
CY2023Q1	cmct	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P1Y
CY2023Q1	us-gaap	Amortization Of Below Market Lease AmortizationOfBelowMarketLease	9000	usd
CY2022Q1	us-gaap	Amortization Of Below Market Lease AmortizationOfBelowMarketLease	69000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	184267000	usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	445059000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	108810000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	232000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	520748000	usd
CY2023Q1	cmct	Line Of Credit Facility Accrued Interest And Unused Commitment Fee Payable LineOfCreditFacilityAccruedInterestAndUnusedCommitmentFeePayable	2000000	usd
CY2022Q4	cmct	Line Of Credit Facility Accrued Interest And Unused Commitment Fee Payable LineOfCreditFacilityAccruedInterestAndUnusedCommitmentFeePayable	562000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	7020000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	87157000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	273279000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	104449000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6759000	usd
CY2023Q1	cmct	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	46364000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	525028000	usd
CY2023Q1	cmct	Number Of Mortgage Loans Assumed NumberOfMortgageLoansAssumed	2	mortgage_loan
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12715000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2811000	usd
CY2023Q1	cmct	Dilutive Securities Effect On Basic Earnings Per Share Redeemable Preferred Stock Dividends DilutiveSecuritiesEffectOnBasicEarningsPerShareRedeemablePreferredStockDividends	0	usd
CY2022Q1	cmct	Dilutive Securities Effect On Basic Earnings Per Share Redeemable Preferred Stock Dividends DilutiveSecuritiesEffectOnBasicEarningsPerShareRedeemablePreferredStockDividends	-1000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12715000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2812000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22707000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23349000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22707000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23351000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q1	cmct	Preferred Stock And Warrants Offering Costs Non Issuance Specific Costs PreferredStockAndWarrantsOfferingCostsNonIssuanceSpecificCosts	9800000	usd
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0.25	shares
CY2023Q1	cmct	Preferred Stock And Warrants Offering Costs Non Issuance Specific Costs PreferredStockAndWarrantsOfferingCostsNonIssuanceSpecificCosts	9800000	usd
	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	192800000	usd
CY2023Q1	cmct	Preferred Stock And Warrants Offering Costs Non Issuance Specific Costs PreferredStockAndWarrantsOfferingCostsNonIssuanceSpecificCosts	9800000	usd
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0.25	shares
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	662462	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4700000	usd
CY2022Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	0	usd
CY2023Q1	cmct	Outstanding Loan Commitments And Approvals To Fund Loans OutstandingLoanCommitmentsAndApprovalsToFundLoans	8000000	usd
CY2023Q1	cmct	Tenant Improvements Obligations TenantImprovementsObligations	7400000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	44197000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	47018000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	28604000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	20657000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	13759000	usd
CY2023Q1	cmct	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	47408000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	201643000	usd
CY2023Q1	cmct	Number Of Types Of Commercial Real Estate Properties NumberOfTypesOfCommercialRealEstateProperties	4	property
CY2022Q1	cmct	Number Of Types Of Commercial Real Estate Properties NumberOfTypesOfCommercialRealEstateProperties	3	property
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7320000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2609000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	256000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	307000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7576000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2302000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-625000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6951000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2297000	usd
CY2023Q1	us-gaap	Assets Assets	957556000	usd
CY2022Q4	us-gaap	Assets Assets	690248000	usd
CY2023Q1	cmct	Capital Expenditures CapitalExpenditures	9112000	usd
CY2022Q1	cmct	Capital Expenditures CapitalExpenditures	1400000	usd
CY2023Q1	cmct	Disposal Group Including Discontinued Operation New Mortgage Loans DisposalGroupIncludingDiscontinuedOperationNewMortgageLoans	10781000	usd
CY2022Q1	cmct	Disposal Group Including Discontinued Operation New Mortgage Loans DisposalGroupIncludingDiscontinuedOperationNewMortgageLoans	22776000	usd
CY2023Q1	cmct	Capital Expenditures And Disposal Group Originations Cost CapitalExpendituresAndDisposalGroupOriginationsCost	19893000	usd
CY2022Q1	cmct	Capital Expenditures And Disposal Group Originations Cost CapitalExpendituresAndDisposalGroupOriginationsCost	24176000	usd

Files In Submission

Name	View Source	Status
0000908311-23-000036-index-headers.html	Edgar Link	pending
0000908311-23-000036-index.html	Edgar Link	pending
0000908311-23-000036.txt	Edgar Link	pending
0000908311-23-000036-xbrl.zip	Edgar Link	pending
cmct-20230331.htm	Edgar Link	pending
cmct-20230331.xsd	Edgar Link	pending
exhibit311q12023.htm	Edgar Link	pending
exhibit312q12023.htm	Edgar Link	pending
exhibit321q12023.htm	Edgar Link	pending
exhibit322q12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
cmct-20230331_def.xml	Edgar Link	unprocessable
cmct-20230331_pre.xml	Edgar Link	unprocessable
cmct-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cmct-20230331_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cmct-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMCT
Creative Media & Community Trust Corp Stock $cmct

2023 Q2 Form 10-Q Financial Statement

#000090831123000036 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMCT Creative Media & Community Trust Corp Stock $cmct

2023 Q2 Form 10-Q Financial Statement

#000090831123000036 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMCT
Creative Media & Community Trust Corp Stock $cmct